Canadian Expert Panel Recommendations on the Management of CNS Symptoms Related to Efavirenz
Efavirenz is a potent antiretroviral agent used in combination with other antiretroviral agents as part of highly active antiretroviral therapy. Efavirenz is generally well tolerated because the majority of its adverse effects are self-limiting, with central nervous symptoms and rash being the most...
Saved in:
Main Authors: | M John Gill, Anita Rachlis, Sharon Walmsley, Mark Halman, The Efavirenz Consensus Working Group |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2001-01-01
|
Series: | Canadian Journal of Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/2001/645147 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Canadian Consensus Guidelines for the Optimal Use of Maraviroc in the Treatment of HIV-Infected Adults
by: Anita Rachlis, et al.
Published: (2010-01-01) -
Pharmacological management of chronic insomnia disorder in Singapore: Recommendations from an expert panel
by: Roger Ho, et al.
Published: (2025-01-01) -
Efficacy of Lurasidone in First-Episode Psychosis: Patient Phenotypes, Dosage, and Recommendations from an Expert Panel
by: Miquel Bernardo, et al.
Published: (2025-01-01) -
Canadian Consensus Conference on the Management of Viral Hepatitis
by: Association for Study of the Liver (CASL) Consensus Conference Rapporteur Group
Published: (2000-01-01) -
Acute Liver Failure among Patients on Efavirenz-Based Antiretroviral Therapy
by: Innocent Lule Segamwenge, et al.
Published: (2018-01-01)